These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 305881)

  • 1. [Anti ENA antibodies in the differential diagnosis of mixed connective tissue diseases].
    Fink G; Machtev I
    Harefuah; 1978 Jan; 94(1):34-5. PubMed ID: 305881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness of determining antinuclear antibodies in the differential diagnosis of inflammatory systemic connective tissue diseases and other childhood diseases].
    Szymańska-Jagiełło W; Musiej-Nowakowska E; Wagner T
    Pediatr Pol; 1985 Mar; 60(3):226-33. PubMed ID: 3876541
    [No Abstract]   [Full Text] [Related]  

  • 3. Grand rounds: diagnostic use of autoantibodies in connective tissue diseases.
    Waller MV
    Va Med; 1979 Mar; 106(3):222-6. PubMed ID: 87064
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 5. [Joint lesions and antibodies to ribonucleoproteins in mixed connective tissue disease].
    Del'barr F; Del'r'e F
    Ter Arkh; 1980; 52(6):62-4. PubMed ID: 6967634
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies against antigens of soluble fraction in rheumatic diseases].
    Ivanova SM
    Ter Arkh; 1981; 53(11):135-9. PubMed ID: 7041312
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibilities of differentiation of antinuclear antibodies].
    Müller W; Rosenthal M; Stojan B
    Z Gesamte Inn Med; 1975 Oct; 30(20):665-71. PubMed ID: 766433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of autoantibodies and the clinical course of mixed connective tissue disease, systemic scleroderma, dermatomyositis, polymyositis and Sjögren's syndrome].
    Prokop J; Zietkiewicz E; Słomski R
    Przegl Dermatol; 1986; 73(4):327-31. PubMed ID: 3333867
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical usefulness of determining the antibodies to soluble nuclear antigens in various collagen diseases].
    Dziankowska-Bartkowiak B; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Torzecka D; Waszczykowska E
    Przegl Dermatol; 1990; 77(5):332-5. PubMed ID: 2125351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnostic and differential diagnostic value of anti-DNA antibodies in collagen diseases, especially in disseminated lupus erythematosus].
    Małdyk H; Chwalińska-Sodowska H; Grabowska A; Swierczynska Z; Rdułtowska B
    Verh Dtsch Ges Rheumatol; 1978; 5():107-9. PubMed ID: 309225
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value and limitations of immunodiagnosis in collagen diseases].
    Błaszeczyk M
    Przegl Dermatol; 1976; (6 Suppl):339-41. PubMed ID: 1088587
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microhemagglutination test for the detection of antibodies against extractable nuclear antigen. Comparative study of different patient groups for ANA, DNA and ENA antibodies].
    Høier-Madsen M; Andersen MG
    Ugeskr Laeger; 1980 Sep; 142(40):2627-30. PubMed ID: 6969484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunologic methods in the differential diagnosis of collagen diseases].
    Kalden JR
    Med Welt; 1975 Dec; 26(50):2242-7. PubMed ID: 765672
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
    Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular fluorescence patterns of antinuclear factors and their diagnostic utilization].
    Holubar K; Doralt M
    Z Haut Geschlechtskr; 1971 Oct; 46(19):708-11. PubMed ID: 4944722
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Sharp syndrome ("mixed connective tissue disease")].
    Rosenthal M
    Schweiz Med Wochenschr; 1976 Jan; 106(5):129-34. PubMed ID: 1082643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of double immunodiffusion method (ENA-1 test) for detecting anti RNP and/or Sm antibodies].
    Miyawaki S; Sakamoto K; Onodera H
    Rinsho Byori; 1985 Sep; 33(9):1025-30. PubMed ID: 3935834
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of anti small nuclear ribonucleoprotein antibody in patients with collagen disease--a comparison of sensitivities of four methods].
    Akashi Y; Tokuda M; Kurata N; Yoshizawa N; Takahara J
    Ryumachi; 1995 Jun; 35(3):552-8. PubMed ID: 7570209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.